These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12598466)

  • 21. [Endoscopically-controlled endonasal orbital decompression in malignant exophthalmos].
    Michel O; Bresgen K; Rüssmann W; Thumfart WF; Stennert E
    Laryngorhinootologie; 1991 Dec; 70(12):656-62. PubMed ID: 1755909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basedow ophthalmopathy: treatment with intravenous immunoglobulins. 2 cases].
    Levesque G; Tabarin A; Lafargue-Gense V; Roger P
    Presse Med; 1994 Feb; 23(8):393. PubMed ID: 8208708
    [No Abstract]   [Full Text] [Related]  

  • 23. Exophthalmos in autoimmune thyroid disease.
    Amino N; Yuasa T; Yabu Y; Miyai K; Kumahara Y
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1232-4. PubMed ID: 6893711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between clubbing and exophthalmos and/or pretibial myxoedema in Graves disease.
    Kundu AK
    J Assoc Physicians India; 1999 Apr; 47(4):462. PubMed ID: 10778547
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical relations between endocrine exophthalmos and thyroid pathology].
    Winand R; Lavergne G
    Rev Med Liege; 1970 Aug; 25(15):473-7. PubMed ID: 4194747
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of the treatment of hyperthyroidism on the course of exophthalmos].
    Vázquez-Chávez C; Nishimura Meguro E; Espinosa Said L; Delgado Falfari A; Sáinz de Viteri M
    Rev Invest Clin; 1992; 44(2):241-7. PubMed ID: 1439313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graves' disease complicating myelopathy.
    Frisbie JH; Fisch B
    Paraplegia; 1992 Aug; 30(8):593-7. PubMed ID: 1523003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-lymphocyte-subsets in endocrine exophthalmos.
    Cenmamo G; Bizzarro A; Castello G
    Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):43-5. PubMed ID: 3879963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverted squamous papilloma with neuro-ophthalmic features.
    Peterson IM; Heim C
    J Clin Neuroophthalmol; 1991 Mar; 11(1):35-8. PubMed ID: 1827457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proptosis in normal Thai samples and thyroid patients.
    Sarinnapakorn V; Sridama V; Sunthornthepvarakul T
    J Med Assoc Thai; 2007 Apr; 90(4):679-83. PubMed ID: 17487121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of sequelae of basedowian exophthalmos].
    Lamas G; Girard B; Rousselie F; Soudant J; Sénéchal G; Chic M
    Ann Otolaryngol Chir Cervicofac; 1988; 105(4):309-12. PubMed ID: 3408104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the first stage of treatment with glucocorticoids and glucocorticoids with azathioprine].
    Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Daniel B
    Endokrynol Pol; 1988; 39(5):229-36. PubMed ID: 3076562
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endocrine exophthalmopathy].
    Biriukova MP
    Probl Endokrinol (Mosk); 1984; 30(6):67-73. PubMed ID: 6393120
    [No Abstract]   [Full Text] [Related]  

  • 36. Utility of rituximab treatment for exophthalmos, myxedema, and osteoarthropathy syndrome resistant to corticosteroids due to Graves' disease: a case report.
    Ferreira-Hermosillo A; Casados-V R; Paúl-Gaytán P; Mendoza-Zubieta V
    J Med Case Rep; 2018 Feb; 12(1):38. PubMed ID: 29448964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endocrine orbitopathy from the viewpoint of the ophthalmologist].
    Otradovec J
    Cesk Oftalmol; 1983 Mar; 39(2):100-7. PubMed ID: 6688040
    [No Abstract]   [Full Text] [Related]  

  • 38. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the treatment by plasmapheresis (stage II) and cobalt teletherapy of orbital tissues (stage III)].
    Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Marzecki Z; Daniel B; Osiński W
    Endokrynol Pol; 1988; 39(5):237-44. PubMed ID: 3255604
    [No Abstract]   [Full Text] [Related]  

  • 39. Eyelid malpositions in Graves' ophthalmopathy.
    Waller RR
    Trans Am Ophthalmol Soc; 1982; 80():855-930. PubMed ID: 6897828
    [No Abstract]   [Full Text] [Related]  

  • 40. [Orbit decompression surgery in patients with exophthalmos caused by Graves-Basedow disease].
    Pliego-Maldonado A; Miranda-Ruiz R; Vargas-Aguayo A; Marín-Méndez JA; Peña-García JF; Guerra-López J
    Gac Med Mex; 2000; 136(1):11-5. PubMed ID: 10721594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.